Search research articles
Contact Us
Filters
Showing results (71-80 of 240) with videos related to
Page
of 24
Sort By:
The American Journal of Psychiatry
|
June 1, 1971
A potential clinical use for methylphenidate with tricyclic antidepressants
R N Wharton, J M Perel, P G Dayton, et al.
Journal of Geriatric Psychiatry and Neurology
|
July 1, 1994
Clomipramine in the elderly: tolerance and plasma levels
M E Kunik, B G Pollock, J M Perel, et al.
Psychopharmacology Bulletin
|
October 1, 1975
Plasma levels of imipramine and clinical outcome
A H Glassman, M Shostak, S J Kantor, et al.
Biological Psychiatry
|
June 5, 1998
Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia
M R Mavissakalian, J M Perel, M Talbott-Green, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1987
Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?
M Shostak, J M Perel, R L Stiller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 29, 1999
Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs
D L Thai, L N Yurasits, G R Rudolph, et al.
The American Journal of Psychiatry
|
December 1, 1993
Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine
J R Cornelius, P H Soloff, J M Perel, et al.
Psychopharmacology Bulletin
|
January 1, 1997
Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns
K L Wisner, J M Perel, R L Findling, et al.
Psychopharmacology Bulletin
|
January 1, 1990
Fluoxetine trial in borderline personality disorder
J R Cornelius, P H Soloff, J M Perel, et al.
The Journal of Clinical Psychiatry
|
April 23, 2008
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
Dorothy K Sit, James M Perel, Joseph C Helsel, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 240) with videos related to
Sort By:
Page
of 24
The American Journal of Psychiatry
|
June 1, 1971
A potential clinical use for methylphenidate with tricyclic antidepressants
R N Wharton, J M Perel, P G Dayton, et al.
Journal of Geriatric Psychiatry and Neurology
|
July 1, 1994
Clomipramine in the elderly: tolerance and plasma levels
M E Kunik, B G Pollock, J M Perel, et al.
Psychopharmacology Bulletin
|
October 1, 1975
Plasma levels of imipramine and clinical outcome
A H Glassman, M Shostak, S J Kantor, et al.
Biological Psychiatry
|
June 5, 1998
Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia
M R Mavissakalian, J M Perel, M Talbott-Green, et al.
Journal of Clinical Psychopharmacology
|
December 1, 1987
Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?
M Shostak, J M Perel, R L Stiller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 29, 1999
Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs
D L Thai, L N Yurasits, G R Rudolph, et al.
The American Journal of Psychiatry
|
December 1, 1993
Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine
J R Cornelius, P H Soloff, J M Perel, et al.
Psychopharmacology Bulletin
|
January 1, 1997
Nortriptyline and its hydroxymetabolites in breastfeeding mothers and newborns
K L Wisner, J M Perel, R L Findling, et al.
Psychopharmacology Bulletin
|
January 1, 1990
Fluoxetine trial in borderline personality disorder
J R Cornelius, P H Soloff, J M Perel, et al.
The Journal of Clinical Psychiatry
|
April 23, 2008
Changes in antidepressant metabolism and dosing across pregnancy and early postpartum
Dorothy K Sit, James M Perel, Joseph C Helsel, et al.
Page
of 24